Discontinued — last reported Q4 '25
Business Segments · Goodwill
CarelonRx Segment — Goodwill
Elevance Health CarelonRx Segment — Goodwill decreased by 0.9% to $1.90B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.9%, from $1.92B to $1.90B.
Analysis
StatementSegment
CategoryGrowth
SignalContext dependent
VolatilityStable
First reportedQ4 2020
Last reportedQ4 2025
Rolls up toGoodwill
How to read this metric
High levels suggest significant historical acquisition activity; a sudden decrease indicates potential impairment charges due to underperformance.
Detailed definition
The excess of the purchase price over the fair value of identifiable net assets acquired in business combinations specif...
Peer comparison
Standard 'Goodwill' reported by peers in the pharmacy benefit management and healthcare services industry.
Metric ID:
elv_segment_carelonrx_goodwillHistorical Data
5 periods
| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $59.00M | $59.00M | $957.00M | $1.92B | $1.90B |
| QoQ Change | — | +0.0% | >999% | +100.1% | -0.9% |
| YoY Change | — | +0.0% | >999% | +100.1% | -0.9% |
Range$59.00M – $1.92B
CAGR>999%
Avg YoY Growth+405.3%
Median YoY Growth+50.1%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx segment — goodwill?
- Elevance Health (ELV) reported carelonrx segment — goodwill of $1.90B in Q4 2025.
- How has Elevance Health's carelonrx segment — goodwill changed year-over-year?
- Elevance Health's carelonrx segment — goodwill decreased by 0.9% year-over-year, from $1.92B to $1.90B.
- What does carelonrx segment — goodwill mean?
- The premium paid for pharmacy services businesses over the fair value of their tangible assets.